16th March 2020|Investor Media, News ProBiotix Health partners with Velinoff Pharma to bring CholBiome® and CholBiome® X3 to Bulgarian market
16th March 2020|Investor Media, News ProBiotix Health extends agreement with Sacco S.r.l. for the manufacturing and supply of its patented probiotic strain LPLDL until 2023
5th March 2020|Investor Media, News A Thriving Partnership: OptiBiotix meets with Maxum Foods in Australia to continue SlimBiome® success
20th February 2020|Investor Media, News OptiBiotix partners with Select Ingredient to bring its patented probiotic strain LPLDL to the US and Canadian markets
18th February 2020|Investor Media, News OptiBiotix announces partnership with Granja Pocha to develop dairy product range containing LPLDL in Uruguay, South America
17th February 2020|Investor Media, News OptiBiotix launches SlimBiome® to North American market in partnership with Agropur Inc.
13th February 2020|News, Scientific Media New OptiBiotix Health LPLDL® formulation demonstrates blood pressure reduction in new human study
13th February 2020|Commercial Media, News OptiBiotix announces Italian market first with pioneering supplement for cholesterol health
